Free Trial

HCA Healthcare (HCA) Stock Price, News & Analysis

HCA Healthcare logo
$304.62 +1.10 (+0.36%)
(As of 12/24/2024 05:19 PM ET)

About HCA Healthcare Stock (NYSE:HCA)

Key Stats

Today's Range
$301.68
$304.62
50-Day Range
$297.52
$415.67
52-Week Range
$268.80
$417.14
Volume
321,264 shs
Average Volume
1.21 million shs
Market Capitalization
$77.16 billion
P/E Ratio
13.68
Dividend Yield
0.87%
Price Target
$385.63
Consensus Rating
Moderate Buy

Company Overview

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
99th Percentile Overall Score

HCA MarketRank™: 

HCA Healthcare scored higher than 99% of companies evaluated by MarketBeat, and ranked 24th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HCA Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 11 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    HCA Healthcare has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about HCA Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for HCA Healthcare are expected to grow by 13.11% in the coming year, from $21.90 to $24.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HCA Healthcare is 13.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.11.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HCA Healthcare is 13.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 87.54.

  • Price to Earnings Growth Ratio

    HCA Healthcare has a PEG Ratio of 1.21. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    HCA Healthcare has a P/B Ratio of 76.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.94% of the float of HCA Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    HCA Healthcare has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCA Healthcare has recently increased by 18.86%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    HCA Healthcare has a dividend yield of 0.89%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    HCA Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of HCA Healthcare is 11.85%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, HCA Healthcare will have a dividend payout ratio of 10.66% next year. This indicates that HCA Healthcare will be able to sustain or increase its dividend.

  • Read more about HCA Healthcare's dividend.
  • Percentage of Shares Shorted

    1.94% of the float of HCA Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    HCA Healthcare has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCA Healthcare has recently increased by 18.86%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    HCA Healthcare has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for HCA Healthcare this week, compared to 17 articles on an average week.
  • Search Interest

    Only 13 people have searched for HCA on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    Only 17 people have added HCA Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -23% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HCA Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,387,650.00 in company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of HCA Healthcare is held by insiders.

  • Percentage Held by Institutions

    62.73% of the stock of HCA Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HCA Healthcare's insider trading history.
Receive HCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCA Healthcare and its competitors with MarketBeat's FREE daily newsletter.

HCA Stock News Headlines

HCA Healthcare Emergency Department Hospital
HCA Healthcare: 4 Reasons to Buy the 25% Dip
Discover why HCA Healthcare stock could be poised for a recovery despite recent setbacks, including hurricane-related expenses and claim denials.
[PDF] The Opportunity in Gold
Commodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.
HCA Healthcare sign vandalized in Nashville
See More Headlines

HCA Stock Analysis - Frequently Asked Questions

HCA Healthcare's stock was trading at $270.68 at the beginning of the year. Since then, HCA stock has increased by 12.5% and is now trading at $304.62.
View the best growth stocks for 2024 here
.

HCA Healthcare, Inc. (NYSE:HCA) issued its earnings results on Tuesday, July, 23rd. The company reported $5.50 EPS for the quarter, beating analysts' consensus estimates of $4.97 by $0.53. The business's revenue was up 10.3% compared to the same quarter last year.
Read the conference call transcript
.

HCA Healthcare's Board of Directors initiated a stock buyback plan on Tuesday, January 30th 2024, which permits the company to repurchase $6,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 7.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its stock is undervalued.

HCA Healthcare subsidiaries include these companies: Valify, Galen College of Nursing, Mission Health, Highlands Regional Medical Center, Weatherford Regional Medical Center, Memorial University Medical Center, Mobile Heartbeat, and more.

HCA Healthcare's top institutional investors include Sanders Capital LLC (4.56%), State Street Corp (3.28%), Wellington Management Group LLP (2.78%) and Geode Capital Management LLC (1.51%). Insiders that own company stock include Thomas F Frist Jr, Charles J Hall, Patricia F Elcan, Bill B Rutherford, Phillip G Billington, Christopher F Wyatt, A Bruce Moore Jr, Michael S Cuffe, P Martin Paslick, Kathryn A Torres, Timothy M Mcmanus, Jon M Foster, Kathleen M Whalen, Sammie S Mosier, Jennifer Berres, Erol R Akdamar, Jeffrey E Cohen, Andrea B Smith, Chad J Wasserman, Michael R Mcalevey, Deborah M Reiner and Joseph A Sowell III.
View institutional ownership trends
.

Shares of HCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that HCA Healthcare investors own include Chevron (CVX), Bristol-Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Last Earnings
7/23/2024
Ex-Dividend for 9/30 Dividend
9/16/2024
Dividend Payable
9/30/2024
Ex-Dividend for 12/27 Dividend
12/13/2024
Today
12/25/2024
Dividend Payable
12/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Health Care Facilities
CUSIP
40412C10
Employees
310,000
Year Founded
1968

Price Target and Rating

Average Stock Price Target
$385.63
High Stock Price Target
$440.00
Low Stock Price Target
$301.00
Potential Upside/Downside
+26.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
18 Analysts

Profitability

Net Income
$5.24 billion
Pretax Margin
12.55%

Debt

Sales & Book Value

Annual Sales
$69.62 billion
Cash Flow
$30.22 per share
Book Value
$3.96 per share

Miscellaneous

Free Float
249,244,000
Market Cap
$77.16 billion
Optionable
Optionable
Beta
1.63

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:HCA) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners